Development and external validation of a clinical prediction model to estimate unfavorable graft outcome in patients with severe kidney transplant rejection eligible for treatment with alemtuzumab

Immunobiology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles